Novartis in the lead to acquire cancer drug developer MorphoSys, sources say

Drug maker Novartis is in advanced talks to acquire MorphoSys, a developer of cancer treatments that has a market value of 1.6 billion euros ($1.7 billion), two people familiar with the matter said on Monday.

Related Keywords

Planegg ,Bayern ,Germany ,German , ,Novartis ,Business ,Biotechnology ,Biotech And Pharmaceuticals ,Pharmaceuticals ,Incyte Corp ,Novartis Ag ,Business News ,